Betiatide for Radiopharmaceutical Preparations
Betiatide for Radiopharmaceutical Preparations Impurities & Reference Standards
As a key active pharmaceutical ingredient (API), Betiatide for Radiopharmaceutical Preparations is used across the pharmaceutical industry in the development and production of finished dosage forms. Betiatide for Radiopharmaceutical Preparations is registered under CAS Number 103725-47-9. The compound carries the molecular formula C15H17N3O6S, corresponding to a molecular weight of 367.4 g/mol. Related substances and impurities of Betiatide for Radiopharmaceutical Preparations are routinely used as reference materials for stability-indicating method development, impurity profiling, and compliance with ICH, USP, BP, and EP monographs. We offer Betiatide for Radiopharmaceutical Preparations and its impurity standards with complete analytical documentation, including CoA and HPLC data, suitable for pharmaceutical quality control and regulatory submissions.
Associated Impurities
Betiatide for Radiopharmaceutical Preparations Impurity – A
- CAS No: 65-85-0
- Mol. F.: C7H6O2
Betiatide for Radiopharmaceutical Preparations Impurity – B
- CAS No: 6398-74-9
- Mol. F.: C9H8O3S
Betiatide for Radiopharmaceutical Preparations Impurity – C
- CAS No:
- Mol. F.: C13H11NO5S
Betiatide for Radiopharmaceutical Preparations Impurity – D
- CAS No: 144616-07-9
- Mol. F.: C13H14N2O5S
Betiatide for Radiopharmaceutical Preparations Impurity – E
- CAS No: 103-46-8
- Mol. F.: C9H10O2S